High Content-High Throughput Drug Screening: Flow Cytometry Rises to Meet the Challenge

摘要

The challenge of bringing flow cytometry into the high throughput-high content world of screening has been significant. Traditionally, flow cytometry has simply not qualified as a high-throughput technology and has been relegated to the high-technology, but irrelevant, side of screening. That perspective can no longer be supported. The technology of flow has finally entered the world of mainstream high-throughput screening and offers a significantly different and expanded capability that will enhance screening capabilities across the entire spectrum.